• Jobs
  • Startups
  • Hire
LoginSign up

Shennon Biotechnologies

Shennon Biotechnologies has 5 open roles, 1 posted in the last 30 days. Stated pay range: $120k – $180k a year. Last round: Sep 14, 2026.

Open roles

  • Shennon Biotechnologies logo
    CMC Lead, Multispecific Antibodies (Director level, consulting)

    Shennon Biotechnologies

    • San Francisco, CA
    • Remote · Director / Executive
    Greenhouse
    Posted 29d ago
  • Shennon Biotechnologies logo
    Head of Droplet-based Microfluidics Applications - Associate Director

    Shennon Biotechnologies

    • San Francisco, CA
    • On-site · Director / Executive
    • $160k–$180k
    Reports to the CTO
    Greenhouse
    Posted 46d ago
  • Shennon Biotechnologies logo
    Scientist/Senior Scientist in T-cell Engager (TCE) Development

    Shennon Biotechnologies

    • San Francisco, CA
    • Senior
    • $120k–$160k
    Greenhouse
    Posted 186d ago
  • Shennon Biotechnologies logo
    Join our Talent Pool!

    Shennon Biotechnologies

    • San Francisco, CA
    • On-site
    Greenhouse
    Posted 820d ago
  • Shennon Biotechnologies logo
    CSO

    Shennon Biotechnologies

    • San Francisco, CA
    • Director / Executive
    Reports to the CEO
    Greenhouse
    Posted 1177d ago

About

Shennon Biotechnologies logo

Shennon Biotechnologies

Shennon Biotechnologies is a biotechnology company developing therapeutics using computational biology and AI-driven drug discovery technologies. Its platform applies machine learning and molecular analysis to identify therapeutic targets, design protein binders, and assess safety. The company focuses on developing treatments for cancer and other diseases through computational and experimental approaches.

Recently raised
Founded2021
HQSan Francisco, United States
Size11–50 employees
Unlock human wisdom
ThesisTermsPrivacy
Industry
Biotechnology Research
Funding
  • Funding round · Sep 14, 2026

Claim shennonbio.com

Work at shennonbio.com? Sign in to claim this org and manage its profile.

© 2026 Saywise Inc.